Key Takeaways & Executive Findings
- •• Integrative multi-omics and machine learning significantly enhance disease subtype classification and biomarker discovery. • Deep learning models, particularly graph neural networks, outperform traditional methods in predicting variant pathogenicity. • Federated learning enables privacy-preserving data sharing across institutions, improving model generalizability. • Explainable AI techniques are crucial for clinical adoption, providing interpretable predictions that align with medical knowledge.
Abstract
The rapid evolution of high-throughput technologies has generated an unprecedented volume of biomedical data, necessitating sophisticated integrative approaches to translate this wealth into actionable clinical insights. This review synthesizes recent advancements in SinoBioData intelligence, focusing on the convergence of multi-omics data (genomics, transcriptomics, proteomics, metabolomics) with advanced machine learning algorithms to drive precision medicine. We systematically examine the current landscape of data integration frameworks, highlighting key methodologies such as deep learning for variant effect prediction, network-based approaches for disease module identification, and natural language processing for mining electronic health records. Critical challenges including data heterogeneity, missingness, and interpretability are discussed, alongside emerging solutions like federated learning and explainable AI. Our analysis reveals that while significant progress has been made, the field is still in its infancy, with major hurdles in standardization and clinical deployment. We propose a roadmap for future research, emphasizing the need for robust validation, transparent reporting, and interdisciplinary collaboration. This review serves as a comprehensive resource for researchers and clinicians aiming to harness the power of SinoBioData intelligence in advancing precision medicine.
1. Introduction
The advent of high-throughput technologies has revolutionized biomedical research, enabling the generation of vast and diverse datasets that capture the molecular intricacies of human health and disease. From whole-genome sequencing to mass spectrometry-based proteomics, these technologies offer unprecedented opportunities to understand disease mechanisms and identify novel therapeutic targets. However, the sheer volume, velocity, and variety of these data pose significant challenges for traditional analytical methods, necessitating the development of sophisticated computational approaches to extract meaningful biological insights.
In response, the field of SinoBioData intelligence has emerged at the intersection of bioinformatics, data science, and artificial intelligence, aiming to integrate and analyze multi-omics data to advance precision medicine. By leveraging machine learning algorithms, researchers can uncover complex patterns and relationships that are not apparent through conventional statistical methods. This review provides a comprehensive overview of recent advancements in this domain, focusing on the integration of omics data with machine learning techniques, the challenges that remain, and the future directions that promise to transform clinical practice.
Loading authentic research manuscript (Pages 1–5)...
CHEN Xia, WANG Yu, LI Jing, ZHANG Wei (2025). Advancements in SinoBioData Intelligence: A Comprehensive Review of Integrative Omics and Machine Learning in Precision Medicine. Chinese Traditional and Herbal Drugs. https://doi.org/10.7501/j.issn.0253-2670.2025.22.2025220
Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.
Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.
Frequently Asked Questions
What is SinoBioData intelligence?
SinoBioData intelligence refers to the interdisciplinary field that combines bioinformatics, data science, and artificial intelligence to analyze and integrate large-scale biomedical data, particularly from Chinese populations, to advance precision medicine and personalized healthcare.
How does machine learning contribute to precision medicine?
Machine learning algorithms can identify complex patterns in high-dimensional omics data, enabling accurate disease classification, prediction of treatment responses, and discovery of novel biomarkers, thereby facilitating tailored therapeutic strategies for individual patients.
What are the main challenges in integrating multi-omics data?
Key challenges include data heterogeneity, missingness, batch effects, and the curse of dimensionality. Additionally, ensuring data privacy and interpretability of models are critical for clinical adoption.
What is federated learning and why is it important?
Federated learning is a decentralized machine learning approach that trains models across multiple institutions without sharing raw data, thus preserving privacy. It is important because it enables collaborative research on sensitive medical data while complying with data protection regulations.
How can explainable AI improve clinical trust?
Explainable AI provides insights into how models make predictions, highlighting relevant features and reasoning. This transparency helps clinicians understand and validate model outputs, fostering trust and facilitating integration into clinical workflows.
Related Technical Papers & Translations
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis
Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials
Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis
Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.